Malignant Bone Marrow Neoplasm — Trials

Malignant Bone Marrow Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

4,609 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,034
Recruiting: 591
Ph III recruiting: 61
Growth YoY: +8.6%
Industry share: 22%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (799)

clinicaltrialsPublishedShowing 101–150 of 708 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07154823	A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies(Aquarius)	recruiting	—	550	Tempus AIINDUSTRY	1	Sep 2, 2026	clinicaltrials
NCT07183878	Venetoclax-Enhanced BUCY vs. Standard BUCY Conditioning in High-Risk AML and MDS Patients Undergoing Allo-HSCT (Ven-BUCY Study)(Ven-BUCY)	recruiting	N/A	138	First Affiliated Hospital of Zhejiang UniversityOTHER